Dew, what's your analysis on Redhill. The RHB-104 Australian data set looks intriguing. the upcoming interim look at RHB-104 for Chron's is for futility or efficacy(or both)? Is there a chance for early stoppage? The company has different assets -- to many for me to analyze. I was wondering what your overall take is at the current share price. Thanks. david
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.